肝硬化隐匿型肝性脑病筛查平台的建立及应用研究
作者:
作者单位:

作者简介:

女,硕士在读,护师

通讯作者:

基金项目:

重庆市技术创新与应用发展专项面上项目(cstc2019jscx-msxmX0117)


Establishment and application of screening platform for covert hepatic encephalopathy in patients with liver cirrhosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 建立肝硬化隐匿型肝性脑病筛查平台,探讨基于平台的早期干预对肝硬化患者的应用效果。 方法 将355例肝硬化患者随机分为对照组(n=180)和观察组(n=175),对照组采用常规随访,观察组在对照组的基础上,实施基于隐匿型肝性脑病筛查平台的随访管理,随访6个月后评价应用效果。 结果 随访6个月后,观察组患者再入院、肝性脑病和死亡发生率显著低于对照组(均P<0.05)。 结论 隐匿型肝性脑病筛查平台的建立,为肝硬化患者构建了早期筛查、随访、健康教育和护患交流的一体化管理平台,有助于隐匿型肝性脑病的早期筛查和干预,可有效改善患者临床结局。

    Abstract:

    Objective To establish a screening platform for covert hepatic encephalopathy in liver cirrhosis patients, and to explore the effect of applying the platform-based early intervention to patients with liver cirrhosis. Methods A total of 355 patients with liver cirrhosis were randomized into two groups:the control group (n=180) received routine follow-up service, while the intervention group (n=175) was subjected to follow-up management based on the covert hepatic encephalopathy screening platform. The intervention effect was evaluated 6 months into follow-up service. Results Six months into follow-up service, the intervention group had lower re-admission rate, incidence rate of hepatic encephalopathy, and mortality rate than those of the control group (P<0.05 for all). Conclusion The screening platform for covert hepatic encephalopathy establishes an integrated management model of early screening, regular follow-ups, health education, and nurse-patient communication, which can realize early screening and intervention of covert hepatic encephalopathy, and improve clinical outcomes of patients.

    参考文献
    相似文献
    引证文献
引用本文

刘思琴,李霞,梁露文,刘姗姗,王可,王小梅.肝硬化隐匿型肝性脑病筛查平台的建立及应用研究[J].护理学杂志,2021,36(21):81-84

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2021-06-10
  • 最后修改日期:2021-08-14
  • 录用日期:
  • 在线发布日期: 2022-12-12